Long non-coding SNHG1 in cancer.
CONCLUSION: SNHG1 likely acts as a useful tumour biomarker for cancer diagnosis, prognosis and treatment.
PMID: 30849309 [PubMed - as supplied by publisher]
Source: International Journal of Clinical Chemistry - Category: Chemistry Authors: Thin K, Tu JC, Sudheesh C Tags: Clin Chim Acta Source Type: research
More News: Bone Cancers | Brain | Cancer | Cancer & Oncology | Carcinoma | Chemistry | Colorectal Cancer | Databases & Libraries | Esophagus Cancer | Gastric (Stomach) Cancer | Gastroenterology | Genetics | Hepatocellular Carcinoma | Ischemic Stroke | Kidney Cancer | Laryngeal Cancer | Liver | Liver Cancer | Molecular Biology | Nasopharyngeal Cancer | Neuroblastoma | Neurology | Osteosarcoma | Renal Cell Carcinoma | Skin Cancer | Squamous Cell Carcinoma | Stroke | Study | Urology & Nephrology